NF 023

CAS : 104869-31-0

Ref. 3D-EEA86931

Informations sur le produit

• Nom: NF 023
• Synonymes: 8,8'-[Carbonylbis(Imino-3,1-Phenylene)]Bis-(1,3,5-Naphthalenetrisulfonic Acid), 6Na, 8,8'-[Carbonylbis(Imino-3,1-Phenylene Carbonylimino)]Bis(1,3,5-Naphthalene-Trisulfonic Acid) Hexasodium Salt, 8,8'-[Carbonylbis(Imino-3,1-Phenylenecarbonylimino)]Bis-1,3,5-Naphthalene-Trisulphonic Acid, Hexasodium Salt, 8,8'-[Carbonylbis(imino-3,1-phenylenecarbonylimino)]bis-1,3,5-naphthalenetrisulfonicacidhexasodiumsalt, 8,8μ-[Carbonylbis(imino-3,1-phenylene carbonylimino)]bis(1,3,5-naphthalene-trisulfonic acid) hydrate hexasodium salt, NF 023 hydrate

Description

NF023 is a drug that has been shown to be effective in treating autoimmune diseases and cancer. It works by binding to the p2y receptor, which is present on the surface of cells. The drug then inhibits the production of cytokines, which are molecules that regulate cellular function and help with cell growth. NF023 has been shown to increase the production of gamma-aminobutyric acid (GABA), a neurotransmitter that helps control pain and inflammation. NF023 also works synergistically with other drugs, such as anti-viral medications, chemotherapy agents, or radiation therapy for cancer treatment.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,162.88 g/mol
• Formule: C₃₅H₂₀N₄Na₆O₂₁S₆
• Degré de pureté: Min. 95%